Companies
Sanofi
STOXX 600Health Care· France

SAN

Status-Quo-Player

Sanofi

$81.02

+2.03%

Open $79.53·Prev $79.41

Delayed

STATUS-QUO-PLAYER

Power Core

Sanofi's moat is the compounding clinical evidence and prescriber lock-in created by Dupixent's multi-indication biologics platform, reinforced by irreplaceable global vaccine manufacturing infrastructure.

Published14 Apr 2026
UniverseSTOXX 600
SectorHealth Care

Direction of Movement

upward

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.
SAN:XPAR — Sanofi — Power Mapping Analysis — L17X — L17X